Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, ...

Today, the scale at which most compounding pharmacies produce drugs — and the frequency of problems arising from their ...

With shares lagging and revenue growth slowing, the market seems to be missing the powerful engine driving HCA's per-share earnings higher.

That's why time isn't just an investor's friend; it's their greatest asset. Compound interest is the process of earning ...

Starting early does not merely add another year of investing; it adds another year for compounding to work, making those ...

The health secretary has advocated for deregulating more peptides, but FDA scientists point to a lack of data about their ...

A 401(k) loan sounds convenient in the moment, but it can actually be quite expensive. Here's the math behind it.

The U.S. Food and Drug Administration's staff reviewers said available evidence does not support allowing compounding ...

The chains of amino acids are increasingly marketed for antiaging and health benefits. However, medical experts say many of ...

This week, FDA career staff scientists said there isn’t enough evidence to allow certain peptides to be produced by ...

True competitive advantages — like a stellar brand reputation, a healthy company culture, or deep technological innovation — cannot be bought or rushed.